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Abstract
Background: Among functional elements of a metazoan gene, enhancers are particularly difficult
to find and annotate. Pioneering experiments in Drosophila have demonstrated the value of
enhancer "trapping" using an invertebrate to address this functional genomics problem.
Results: We modulated a Sleeping Beauty transposon-based transgenesis cassette to establish an
enhancer trapping technique for use in a vertebrate model system, zebrafish Danio rerio. We
established 9 lines of zebrafish with distinct tissue- or organ-specific GFP expression patterns from
90 founders that produced GFP-expressing progeny. We have molecularly characterized these
lines and show that in each line, a specific GFP expression pattern is due to a single transposition
event. Many of the insertions are into introns of zebrafish genes predicted in the current genome
assembly. We have identified both previously characterized as well as novel expression patterns
from this screen. For example, the ET7 line harbors a transposon insertion near the mkp3 locus
and expresses GFP in the midbrain-hindbrain boundary, forebrain and the ventricle, matching a
subset of the known FGF8-dependent mkp3 expression domain. The ET2 line, in contrast,
expresses GFP specifically in caudal primary motoneurons due to an insertion into the poly(ADP-
ribose) glycohydrolase (PARG) locus. This surprising expression pattern was confirmed using in situ
hybridization techniques for the endogenous PARG mRNA, indicating the enhancer trap has
replicated this unexpected and highly localized PARG expression with good fidelity. Finally, we
show that it is possible to excise a Sleeping Beauty transposon from a genomic location in the
zebrafish germline.
Conclusions: This genomics tool offers the opportunity for large-scale biological approaches
combining both expression and genomic-level sequence analysis using as a template an entire
vertebrate genome.
Background
Human, mouse and rat genomes likely have less than 40
000 genes each [1-4]. This is only two to three times as
many genes as in Caenorhabditis elegans and Drosophila
melanogaster, and only six times as many as Saccharomyces
cerevisiae [5-7]. The increased complexity of vertebrates
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number. A part of the increased complexity is thought to
be accomplished by alternative splicing, RNA editing and
the use of protein modifications to generate a variety of
protein products from a single gene, but everything starts
with increased complexity at the level of transcriptional
regulation. While promoters are relatively simple and
short in yeast, their complexity increases in multicellular
organisms, making regulatory sequences ever harder to
identify. In humans, enhancer elements can be located
over a megabase away from the transcriptional start site
[8]. Furthermore, current gene prediction programs used
to annotate genomes often fail to correctly identify the 5'
start site of a transcription unit, making in silico analysis of
the regulatory sequences even more complex. To further
complicate the matter, enhancer sequences diverge in evo-
lution, co-evolving with their respective transcription fac-
tors, and often do not work across large evolutionary
distances – worm to fly, for example [9]. This makes infor-
mation from non-vertebrate model systems sometimes
inapplicable to vertebrate sequences.
Enhancer detection ("trapping") using insertion site con-
text vectors was popularized as a genomics tool in Dro-
sophila. The first fly enhancer trap vectors were based on
the P element transposon and often used the transposase's
own promoter fused to the beta-galactosidase reporter
gene for enhancer detection [10-12]. Several of the
enhancer trap lines were shown to express the LacZ
reporter in cells corresponding to the expression patterns
of nearby genes, validating the approach [12,13]. In other
work, promoters such as engrailed, fushi tarazu and Hsp70
were successfully developed for enhancer trapping in the
fruitfly [14-16]. Further modifications to the system
included the implementation of a bipartite system with a
Gal4 transactivator [17], green fluorescent protein (GFP)
[18], and even a GFP-LacZ fusion protein [19] as report-
ers. In addition to the P element, other transposons such
as hobo and piggyBac with insertion site preferences dis-
tinct from those of the P element have been used in Dro-
sophila [20,21]. The availability of a variety of
transposons, promoters and reporters for enhancer trap-
ping in the fruitfly enabled researchers to obtain enhancer
trap insertions into a considerable fraction of Drosophila
genes (reviewed by [22]) and allows an investigator to
choose vectors most suitable for the problem at hand.
The ability to excise from a genomic location has been
instrumental to the utility of P element based vectors. For
mutation-causing insertions, reversion of the mutant phe-
notype by P element excision proves that a given insertion
causes the mutation. Since the mutagenicity of Drosophila
enhancer trap transposons is not significantly higher than
the average 15% rate obtained with regular P elements,
most insertions do not result in a mutation [22]. In these
instances, the P element's ability to induce genomic dele-
tions by "imprecise excision" can be used to obtain a
mutation in the neighboring gene(s) [23].
The success of enhancer trapping in Drosophila prompted
application of this approach in the mouse [24-27]. As was
the case in Drosophila, the lacZ reporter was shown to be
expressed in part of the target gene's expression domain
[28]. Despite the considerable success of these early exper-
iments, enhancer detection as an experimental approach
in mouse was not explored further, giving way to different
versions of gene traps (for a review, see [29]).
We believe the success of enhancer trapping in Drosophila
can be largely attributed to the advantages of this experi-
mental system over mouse. In Drosophila, large numbers
of transgenic organisms can be readily generated and
screened for gene expression patterns. It is far less practical
in the mouse. This is partly due to the availability of effi-
cient and precise transgene delivery tools in the fruitfly:
the native P element, hobo and piggyBac transposons. In
contrast, early mouse experiments were carried out by
non-facilitated DNA transgenesis. This approach is less
efficient and prone to induce deletions and other genome
rearrangements in the recipient locus, as noted in the first
published mouse enhancer trap locus [25,30]. The com-
pact nature of the Drosophila genome also contributed to
the success of enhancer trapping, making the path from
an enhancer trap insertion to the identification of the
affected gene straightforward, especially once the Dro-
sophila genome was sequenced.
The zebrafish Danio rerio is a vertebrate model system that
provides many of the advantages found in invertebrates. A
few hundred transparent, externally developing embryos
can be obtained from a single pair of fish per week. The
zebrafish genome is about two-fold smaller than the
mouse genome, and its sequencing and annotation are
nearing completion. Finally, transposon tools for efficient
and precise transgene delivery into the zebrafish genome
are available. We focused our research on the Sleeping
Beauty (SB) transposon system [31,32]. While not as effi-
cient as the highest titer retrovirus used in zebrafish
[33,34], the Sleeping Beauty transposon system offers
advantages in expression as well as ease of construction
and testing of diverse vectors that can be done using basic
molecular biology tools. Furthermore, the SB system
offers the possibility of transposase-induced excision out
of the genome to induce local deletions or to revert possi-
ble mutant phenotypes.
In this report, we investigated the potential of the SB
transposon system for enhancer detection in zebrafish.
Our results indicate that zebrafish enhancer trap lines
with diverse GFP expression patterns can be readilyPage 2 of 15
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harbor a single transposon insertion event, facilitating the
rapid identification of transposon insertion sites responsi-
ble for specific GFP expression patterns. We show that two
enhancer trap lines exhibit GFP expression patterns
matching the expression patterns of the target genes, and
that both expected and novel gene expression patterns can
be identified using this genomics tool. We conclude that
enhancer trapping using the Sleeping Beauty transposon
system is a viable experimental approach using as tem-
plate a vertebrate genome.
Results
The Sleeping Beauty transposon can detect enhancers in 
cis
We have previously established multiple zebrafish lines
using SB transposons with ubiquitous and tissue-specific
promoters driving reporter expression [32]. Surprisingly,
we did not observe any dependency of the expression pat-
tern on the genomic context of the transposon insertion.
Multiple studies describing insertion-site dependent
transgene expression in vertebrates have suggested that
many of those events are due to the transgene falling
under control of nearby enhancers [35-40]. For enhancer
detection approaches it is imperative that the reporter
gene be sensitive to neighboring transcriptional regula-
tory elements. At least three explanations can be put for-
ward to explain the absence of expression patterns in our
previous work in zebrafish. First, the Sleeping Beauty
transposons are flanked by relatively large inverted
repeats. These repeats might function as silencer elements
and not allow for transcriptional regulation across them.
Second, the promoter we used (Xenopus laevis EF1α,
[41]) may not be subject to transcriptional regulation by
tissue-specific enhancers. Third, the expression level from
the selected promoter may be too high to be effectively
modulated, as enhancer traps usually contain attenuated
promoters. To test these hypotheses, we decided to pro-
duce an artificial enhancer trapping event by cloning a tis-
sue-specific promoter / enhancer just outside the inverted
repeats and test for an increase in tissue-specific expres-
sion in injected embryos (Figure 1). We started with the
transposon used in our previous work, pT2/S1EF1α-GM2,
which contains a shortened version of the Xenopus laevis
EF1α promoter driving the GM2 version of GFP in a pT2
transposon vector [32]. We took advantage of the observa-
tion that relatively few pT2/S1EF1α-GM2 injected
embryos express GFP in the eye. We added a lens-specific
Xenopus laevis γ1-Crystallin promoter [42] to the pT2/
S1EF1α-GM2 vector, as we had previously shown that this
promoter specifically expresses in the lens of injected (F0)
and transgenic (F1) zebrafish [32]. Embryos injected with
pT2/S1EF1α-GM2 or γ Cry1/pT2/S1EF1α-GM2 were
scored for any GFP fluorescence and for eye-specific GFP
fluorescence at 3 dpf (Figure 1). The addition of γ Cry1 to
pT2/S1EF1α-GM2 caused a modest (two-fold) increase in
injected embryos showing any GFP fluorescence. In con-
trast, the increase in eye-specific GFP expression was ten-
fold (Figure 1). We concluded that at least in this assay,
the Sleeping Beauty inverted repeat sequences do not
block transcriptional regulation and that the EF1α pro-
moter can be subject to transcriptional regulation from
external, tissue-specific regulatory sequence elements.
Promoter truncations and pilot screens
We next tested the hypothesis that the absence of expres-
sion patterns in our previous work was due to the fact that
S1EF1α is expressed too strongly in transgenic animals.
Since most successful enhancer traps in Drosophila and
mice were based on truncated or weak promoters, we
decided to attenuate the S1EF1α promoter by removing
sequences upstream of Bst1107I (S2EF1α) and EcoRI
(S3EF1α) restriction enzyme sites (Figure 2). We then co-
injected the corresponding transposon constructs with
SB10 transposase mRNA to assess germline transmission,
expression and enhancer trapping rates. In pilot experi-
ments, progeny from over 20 fish were screened with each
construct. While overall germline transmission and
expression rates were comparable (Figure 2), there was a
difference in the expression patterns of the two constructs
in transgenic embryos. Most of the transgenic animals
generated with pT2/S3EF1α-GM2 exhibited weak GFP
expression, and we could not detect any expression pat-
terns (data not shown). In contrast, when pT2/S2EF1α-
Artificial enhancer trapping with a Sleeping Beauty transposonFigure 1
Artificial enhancer trapping with a Sleeping Beauty 
transposon. Comparison of GFP expression in embryos 
injected with pT2/S1EF1α or γCry1/pT2/S1EF1α. Plasmids are 
diagramed as cartoons on the top of the picture. The SB 
transposon's inverted repeats are shown as boxes with open 
triangles, and the GFP open reading frame is depicted as a 
grey arrow. The gamma-Crystallin promoter/enhancer is 
shown as a hatched box. DNA-injected embryos which sur-
vived to 3 dpf were counted and scored for GFP fluores-
cence anywhere in the embryo (any GFP) and for 
fluorescence in the eye (eye GFP), even if there was addi-
tional fluorescence elsewhere. The average percentage of 
embryos positive for particular GFP fluorescence in three 
independent experiments is shown ± standard deviation.Page 3 of 15
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fairly strong, ubiquitous expression. Closer analysis indi-
cated that many of these "ubiquitous" expression patterns
were rather unique, with GFP expression often noted to be
particularly strong in some tissues, consistent with a tis-
sue-specific expression pattern superimposed on a ubiqui-
tous expression pattern (data not shown). In most cases,
GFP expression segregated as a single integration event,
indicating that a tissue-specific expression pattern was not
likely being masked by a ubiquitous expression pattern
from a different insertion event. A similar phenomenon
has been observed with Drosophila enhancer traps [11].
We speculate that in those instances, the GFP expression
cassette may have fallen under the control of multiple
enhancers – some tissue-specific, some ubiquitous. Alter-
natively, the ubiquitous expression may stem from the
ubiquitous activity of the EF1α promoter used in the
screen, with tissue-specific enhancers only elevating the
expression levels in certain tissues, but not restricting it.
We did not consider such expression patterns valuable
and did not establish any fish lines with such GFP expres-
sion. Importantly, one of the founders in the pT2/S2EF1α-
GM2 pilot screen yielded three kinds of GFP expression in
its progeny. Some were ubiquitously GFP positive, some
showed a hatching gland-specific expression profile, and
some exhibited both. When three F1 fish with both
ubiquitous and hatching gland specific expression were
raised and outcrossed, the two expression patterns exhib-
ited independent segregation: 24% of the embryos were
GFP negative, 26% expressed GFP ubiquitously, 25% had
hatching gland-specific GFP expression, and 25% had
both hatching gland-specific and ubiquitous expression
(n = 245). Independent segregation indicates that the two
transposon insertions causing the two expression patterns
are unlinked. Two independent integration events were
confirmed by Southern hybridization and inverse PCR
(data not shown). The hatching gland-specific GFP
expressing embryos were used to establish our first
enhancer trap line, ET1 (Figure 3A). We concluded from
our pilot screens that pT2/S2EF1α-GM2 demonstrated the
desired properties for potential use in enhancer trapping
studies.
Germline excision of a Sleeping Beauty transposon 
insertion
We have previously demonstrated the excision of a Sleep-
ing Beauty transposon from the genome in somatic tissues
of transposase-injected zebrafish embryos [43]. We tested
if such an excision event could be inherited by examining
transposon excision in the germline. Embryos
homozygous for the ET1 insertion were injected with
SB10 transposase mRNA, and while some were used for a
somatic excision assay the rest were raised to test for germ-
line transmission of an excision event. A PCR reaction on
genomic DNA from transposase-injected embryos with
primers flanking ET1 insertion point produced two bands.
A large band corresponded in size to the transposon inser-
tion allele, and a small band corresponded to a transpo-
son-less allele (data not shown). Both cannonical Sleeping
Beauty transposon footprints (ATGTCAT and ATGACAT,
[44,45]) were obtained upon cloning and sequencing of
the smaller band, indicating a transposase-mediated exci-
sion and DNA repair. 26 fish were screened for germline
transmission (see Materials and Methods), and one was
shown to transmit the expected excision footprint. We
conclude that the Sleeping Beauty transposon can be
excised from a genomic location in the zebrafish
germline.
pT2/S2EF1α-GM2 scale-up screening: 10% of GFP-
expressing integrations yield tissue-specific patterns
One tissue-specific expression pattern was recovered from
our pilot screen. We sought to recover more patterns and
to test if enhancer detection in zebrafish is amenable to
scale-up. To that end, we co-injected 3248 zebrafish
EF1α promoter truncations and endogenous enhancer trap screeningFigure 2
EF1α promoter truncations and endogenous 
enhancer trap screening. A diagram of the S1EF1α pro-
moter [32, 41]. Restriction enzyme sites are shown on top as 
single letters. S is SphI, N is NheI, B is Bst1107I and R is EcoRI. 
G/C, G and C rich box. Sp1, Sp1-like site. TATA, TATA box. 
Numbering below is relative to the first T of the TATA box. 
The table below the diagram shows the results of the pilot 
and scale-up (*) screens. Transgenesis and expression rates 
are shown, non-expressing transposon insertions were not 
scored. Transgenesis and expression rate from scale-up 
screen (#) is an underestimate since many founders were 
screened by incross and crosses from doubly transgenic 










Transposon      Screened Transgenesis Recovered
and Expression Patterns
n n % n %
pT2/S3EF1a/GFP 23 8 35% 0 0%
pT2/S2EF1a/GFP 26 10 39% 1 10%
pT2/S2EF1a/GFP * 330 80 24%# 8 10%
-51 1Page 4 of 15
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Enhancer trap lines exhibit a variety of unique GFP expression patterns. (A). Lateral view of GFP expression in 
Enhancer Trap line 1 (ET1) at 38 hours post fertilization (hpf). (B) ET3 at 5–6 somite stage. (C) ET3 at 36 hpf. (D) ET4 at 26 
hpf. (E) ET5 at 30 hpf. (F) ET5 at 48 hpf. (G) ET6 at 26 hpf. (H) ET7 at 32 hpf. (I) Ventral view of ET7 at 5 dpf. (J) Lateral view 
of ET8 at 26 hpf. (K) Dorsal view of ET9 at 28 hpf. (L) Lateral view of ET9 at 30 hpf. In all panels, anterior is to the left. See text 
for details.Page 5 of 15
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mRNA mix. 2102 embryos survived to day 3 for scoring,
of which 848 were mosaic GFP positive and were selected
to be raised. 330 survived to adulthood and were screened
for germline transmission of GFP expression, primarily by
sibling incrossing. This approach provided a lower esti-
mate of the transgenesis and expression rate because it
does not distinguish instances were both parents are
transgenic. In this screen, at least 80 of the founder fish
produced GFP-expressing progeny resulting in a mini-
mum estimate of a 24% transgenesis rate. The actual
transgenesis rate is closer to 30% because most of the fish
were screened by incross, and if a pair produced GFP-
expressing progeny, only one parent was counted as a
transmitter. Eight of the GFP-expressing fish displayed
distinct GFP expression patterns (Figure 3). Together with
the pilot screen, 9 tissue-specific expression lines were
obtained from 90 transgenic founder fish (10%) using the
pT2/S2EF1α-GM2 transposon.
Recovered expression patterns label a diverse array of 
tissues during embryogenesis
GFP expression in ET1 can be first observed in the polster
region at 7–8 somite stage (not shown). The expression is
very pronounced between 20 and 40 hours post-fertiliza-
tion (hpf), when it marks the hatching gland (Figure 3A).
Expression disappears as the hatching gland is resorbed.
Line ET3 represents a pattern with the earliest onset of
expression. Anterior localization of GFP in the dien-
cephalon is detected by 5–6 somite stage in this line
(Figure 3B). Extremely bright anterior expression persists
in the ventral diencephalon (Figure 3C) and by 6 days
post-fertilizations (dpf) is restricted slightly more poste-
rior in the midline. The onset of expression for ET4 is 18
hpf with a bilateral expression pattern in cranial sensory
ganglia that remains strong until 2 dpf and is undetectable
by 5 dpf. This anterior expression in ET4 seems to label
the lateral line ganglia both anterior and posterior to the
otic vesicle (Figure 3D), however, no expression is
detected in the lateral line in the trunk. In ET5 a single
bilateral patch of strong GFP expression in the hyoid arch
is observed by 24 hpf (Figure 3E), that by 48 hpf marks a
more anterior location in the embryo (Figure 3F). Expres-
sion in this line is greatly diminished by 3 dpf and is
undetectable by 5 dpf. Strong GFP expression is observed
in ET6 by 26 hpf as a bilateral expression pattern consist-
ing of two distinct patches in a subset of cranial sensory
ganglia/placodes (Figure 3G). The expression weakens by
2 dpf and is undetectable by 3 dpf. GFP expression in ET7
begins weakly in the midbrain-hindbrain boundary
(MHB) at 12–14 somites with the most pronounced
expression in the anterior side of the MHB detected by 26
hpf (Figure 3H). Robust expression in the heart is first
detected at around 32 hpf and remains ventricle-specific
through 5 dpf (Figure 3I), even though expression in the
brain is no longer restricted to the MHB. GFP expression
in ET8 is already localized by 10–12 somites and remains
strong in the telencephalon, and posterior side of the
MHB through 26 hpf (Figure 3J). By 3 dpf the localized
anterior expression is undetectable over autofluorescence,
however, caudal expression appears to be enhanced in the
dorsal neural tube. The onset of expression in ET9 occurs
around 22 hpf and is difficult to detect by 2 dpf. At 28–30
hpf (Figure 3K,3L), three distinct expression domains are
apparent in the telencephalon, diencephalon and hind-
brain of ET9.
The ET2 line expresses GFP specifically in the 
motoneurons
We analyzed the ET2 line in detail because of the highly
specific expression of GFP in these fish. GFP expression
was first observed at the 16 somite stage, when 2 bilateral
cells in the spinal cord of the 10 anterior somites become
GFP positive (Figure 4). At later stages, multiple cells per
somite become GFP positive, either due to continued
expression of GFP mRNA or due to segregation of GFP to
daughter cells. GFP expression follows the wave of somi-
togenesis, with the posterior-most somites lagging in GFP
expression. At about 24 hours, ventrally-projecting axons
become visible by GFP fluorescence. Later yet a pattern of
nodes appears along the axons (Figure 4). Based on the
position of neuronal cell body and the axonal trajectory,
we conclude that caudal primary motoneurons express
GFP in this line [46]. To our knowledge, this is the first
gene to be specifically expressed only in this subpopula-
tion of motoneurons. We therefore sought to identify the
locus tagged by this transposon insertion.
Southern analysis indicated that there is a single transpo-
son insertion in this line, and it is linked to GFP expres-
sion (Figure 5). Inverse PCR identified a transposase-
mediated insertion into a TA dinucleotide at position
256083 on contig ctg9701 (zebrafish genome assembly
Zv3). The insertion occurred into a Genescan-predicted
gene. Further analysis indicated that the Genescan-pre-
dicted gene actually consists of parts of at least two differ-
ent genes, myoferlin and poly(ADP-ribose)
glycohydrolase (PARG). The insertion located in the
PARG part of the predicted transcript, 649 nucleotides
from an exon just upstream of the PARG catalytic site. To
confirm that the transposon insertion into the PARG gene
induced GFP expression in primary motoneurons, we pre-
pared genomic DNA from both GFP positive and GFP
negative embryos from an independent outcross, and we
conducted a PCR with NeuroIns-F1 and NeuroIns-R1
primers specific to the flanking sequences. In GFP nega-
tive embryos, a 0.5 kb band corresponding to wild type
locus is noted. In GFP positive embryos, the same band is
seen in addition to a larger band of approximately 2.4 kb,
corresponding to a locus with transposon insertionPage 6 of 15
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performed on DNA from different batches of embryos, we
can exclude the possibility of DNA contamination or fish
husbandry error and conclude that the enhancer trap
transposon insertion into the PARG gene causes GFP
expression in caudal primary motoneurons.
GFP expression in ET2 line matches the expression of the 
endogenous PARG gene
Poly(ADP-ribosyl)ation is a protein modification that is
extensively studied at the biochemical level and is associ-
ated with changes in DNA replication, recombination,
repair and transcription [47], for a review, see [48].
Recently poly(ADP-ribosyl)ation was demonstrated to
have a role in long term memory in the sea slug Aplysia
[49]. Most organisms have multiple genes for poly (ADP-
ribose) polymerases but only a single known gene for poly
(ADP-ribose) glycohydrolase [48]. PARG activity is noted
to be expressed in many cell lines, among them neuronal
[50-53], but the tissue specificity of PARG expression dur-
ing embryogenesis has not been reported for any organ-
ism. To test if the pT2/S2EF1α-GM2 enhancer trap
recapitulates the expression pattern of the endogenous
PARG gene, we conducted whole mount in situ hybridiza-
tion on ET2 outcross embryos to compare PARG and GFP
reporter expression (Figure 6). In situ hybridization visu-
alizes axonal cell bodies, the position of which appears
indistinguishable with both PARG and GFP probes. We
therefore conclude that GFP mRNA expression in this
enhancer trap line faithfully recapitulates the expression
of the zebrafish PARG gene during embryogenesis.
Molecular analysis of other enhancer trap lines identifies 
target genes
We characterized insertion events in other enhancer trap
lines. GFP positive F1 or F2 fish were outcrossed, and
embryos were sorted into GFP positive and GFP negative
pools. Genomic DNA was prepared from each pool, and
Southern analysis was conducted to assess transposon
copy number and linkage to the GFP expression pattern.
In all lines except ET1 (see above), a single GFP expres-
sion-linked transposon insertion event was detected by
Southern hybridization. We then conducted inverse PCR
analysis on the DNA from GFP positive embryos to
The ET2 transgenic fish line expresses GFP in caudal primary motoneuronsFigure 4
The ET2 transgenic fish line expresses GFP in caudal primary motoneurons. GFP expression in ET2 was visualized 
in motoneurons using a bandpass GFP filter set at various stages of embryonic development. In all panels anterior is to the left. 
(A) The onset of GFP expression in ET2 line at 16 somite stage. (B) 26 somite stage. (C) 24 hpf. (D, E) 36 hpf. Axonal trajecto-
ries are visible at 24 and 36 hpf.
A B C
D EPage 7 of 15
(page number not for citation purposes)
BMC Genomics 2004, 5:62 http://www.biomedcentral.com/1471-2164/5/62identify the insertion locus. For verification, DNA from
embryos from an independent outcross was prepared and
PCR was run with primers flanking the insertion site to
link GFP expression and transposon insertion at a partic-
ular locus. Verified enhancer trap loci are presented in
Table 1. Notably, seven of the insertions have occurred
into introns of Genescan-predicted genes. Four of the
tagged genes show significant homologies to previously
identified genes: PARG (see above), MAPK upstream
kinase-binding inhibitory protein (MBIP) [54], a member
of cytochrome P450 superfamily and Nidogen [55]. The
other three tagged predicted genes do not have significant
homologies to previously identified genes. In the two
lines which have insertions into intergenic regions, trans-
posons have integrated less than 25 kb from the nearest
predicted transcript.
ET7 line has a transposon insertion near mkp3 locus and 
matches mkp3 expression pattern
The transposon insertion in ET7 line has occurred into a
predicted novel gene (Table 1). Closer investigation of the
target locus revealed the presence of a previously charac-
terized zebrafish mkp3 gene within 30 kb of the insertion
site. Our attempts to amplify the predicted novel candi-
date gene from maternal and post-somitogenesis
zebrafish cDNA libraries using 2 different primer pairs
failed, while mkp3 cDNA was readily amplified in parallel
PCR reactions (data not shown). This suggests that the
novel target gene may be a false prediction by Genescan.
The mkp3 gene encodes a dual specificity phosphatase
which was cloned as a member of fgf8 synexpression
group and is a negative feedback regulator of FGF8 signal-
ing. mkp3 is expressed in the midbrain-hindbrain bound-
ary, forebrain, tailbud, branchial arches, developing ear,
pectoral fin buds and other tissues [56,57]. GFP expres-
sion in ET7 line closely mimics mkp3 mRNA expression
pattern in 23 hour embryo (Figure 7). The only significant
difference is that GFP expression is stronger in somites
and not as bright in the tailbud, even though the tailbud
expression becomes brighter at later stages of develop-
ment (data not shown). We did not observe GFP expres-
sion in the pectoral fin buds, even though we reproduced
mkp3 expression in the fin buds just after after 24 hpf by
in situ (data not shown, [56,57]. An intriguing possibility
is that mkp3 expression in pectoral fin buds may be con-
trolled by a different enhancer, one we do not detect in
this transgenic line. Additionally, ET7 expresses GFP in
the heart after 24 hpf, and the expression clearly localizes
to the ventricle at 5 dpf (Figure 3I). Expression of mkp3 in
the heart after 24 hpf was not reported, and we did not
conduct in situ hybridization on late pharyngula stage
embryos to test for it. However, fgf8 is expressed in the
ventricle of the zebrafish heart at 36 hpf [58]. Taken
together, this suggests that GFP expression in ET7 line
mimics a subset of the complete expression pattern of the
zebrafish mkp3 gene.
Discussion
In this paper, we describe the first use of enhancer trap-
ping, or enhancer detection, as an experimental approach
in zebrafish. We show that Sleeping Beauty transposons
can trap enhancers by testing an artificial enhancer trap-
ping event in vivo. This approach is likely to also be useful
in the construction and testing of other trap vectors: gene
(5' exon) and polyA (3' exon) and other related con-
structs. We then constructed two further truncations to the
S1EF1α promoter in the transgenesis cassette [32] and
found one to be particularly suitable for enhancer trap-
ping. Ten percent (9 of 90) of GFP-expressing transgenic
Identification of the transposition event in the ET2 lineFigure 5
Identification of the transposition event in the ET2 
line. (A) The pT2/S2EF1α transposon insertion into zebrafish 
genome is shown; restriction enzyme sites and primers used 
for molecular analysis are indicated. Transposon IR/DR's are 
shown as solid boxes with open triangles, and the GFP open 
reading frame is shown as a grey arrow. Genomic DNA is 
shown as a dotted line. N is NsiI, E is EcoRV. (B) Southern 
blot on ET2 line outcross embryos. DNA from GFP positive 
(lanes 1 and 2) and GFP negative (lanes 3 and 4) embryos was 
digested with NsiI (lanes 1 and 3) or EcoRV (lanes 2 and 4) 
and probed with a GFP-specific probe. (C) Linkage of the 
transposon insertion event to GFP expression. Primers flank-
ing the transposon insertion event (arrows) were used to 
conduct PCR on DNA from GFP positive (lane 2) and GFP 
negative (lane 3) embryos from an ET2 outcross different 




APage 8 of 15
(page number not for citation purposes)
BMC Genomics 2004, 5:62 http://www.biomedcentral.com/1471-2164/5/62fish generated lines with unique GFP expression patterns.
All reagents described in this paper, including the
enhancer trap fish strains, are readily available upon
request http://beckmancenter.ahc.umn.edu.
Many of the obtained enhancer trap lines express GFP in
the nervous system. This was previously observed with
both mouse and Drosophila enhancer trap vectors and was
speculated to stem from the transcriptional complexity of
neural tissue [11,28]. Several of our lines also exhibit
some level of GFP expression in the eye. At least two expla-
nations can be put forward to explain this observation.
First, many genes are expressed in the developing eye.
Thus, the eye expression that we see may reflect expression
of the tagged genes in the eye. Second, optical properties
of the tissues in the eye may permit detection of GFP
expression that is lower that what would be required for
detection in other tissues.
The ET2 line harbors a transposon insertion into the
zebrafish gene for poly(ADP-ribose) glycohydrolase
(PARG). We demonstrate that both PARG and GFP in ET2
line are expressed in caudal primary motoneurons of 23
hour old embryos. Thus, GFP expression in the ET2 line
GFP expression in ET2 line embryos is indistinguishable from endogenous PARG gene expressionFigure 6
GFP expression in ET2 line embryos is indistinguishable from endogenous PARG gene expression. 23 hpf 
embryos collected from a heterozygous outcross were photographed for GFP fluorescence and sibling embryos were fixed for 
in situ hybridization. (A) In situ hybridization with PARG antisense probe. (B) In situ with GFP antisense probe. (C) Visualization 
of GFP expression in living embryos using a bandpass GFP filter set. (D) The same embryo as in (C) photographed using a 
bandpass GFP filter set with a low level of bright field illumination to visualize GFP expression in relative position to the 
somites.Page 9 of 15
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that transgene expression is under control of an endog-
enous enhancer. A very intriguing question is what the
actual trapped enhancer sequence is, how far away from
the genomic enhancer the trap can insert and still detect it,
and weather artificial enhancer trap approach (Figure 1)
can be used to answer these questions.
The ET7 line has a transposon insertion into a predicted
novel gene 30 kb downstream of the zebrafish mkp3 locus.
GFP expression in that line closely resembles part of the
mkp3 expression domain, suggesting that the enhancer
trap transposon in that line is under control of a subset of
mkp3 enhancer elements.
Zebrafish enhancer trap lines will be valuable in future
developmental genetics studies, be it classical mutagene-
sis or morpholino "knockdown" screening [59]. GFP
expression can be used as a sensitive marker for certain tis-
sue or cell types. For example, the ET1 line expresses GFP
in the hatching gland. The expression of the hgg1 gene is
specific to the polster and hatching gland depends on
nodal signaling and is absent in one-eyed-pinhead mutants
[60]. We phenocopied the one-eyed-pinhead mutation by
GFP expression in ET7 line matches mkp3 mRNA expressionFigure 7
GFP expression in ET7 line matches mkp3 mRNA expression. (A) GFP fluorescence photograph of an ET7 embryo at 
23 hpf. (B) In situ hybridization on 23 hpf wild type embryo using mkp3 antisense RNA probe.
Table 1: pT2/S2EF1α-GM2 transposon insertion events in analyzed enhancer trap lines.
Trap line Sequence Insertion location Predicted gene
ET1 ATTGTCCtTAGTGTATGTGTTTGTGTGA Chr. 4 none
ET2 CAAAAAGACTATATATAGGAGGCTTCAA ctg9701 PARG
ET3 AACGCTTACCATGTATGTTAATAAATGT Chr. 17 MBIP
ET4 TATATCAAAATTATATATATGAACGTAT Chr. 6 Cyt. P450
ET5 GTACATAcACATGTACAAATCaACATTA ctg13471 novel
ET6 ATTTTAAACAAACTAAGTtGAACATTAC ctg13605 Nidogen
ET7 ATCACAGAGCATCTAGCTTGGATGTGCT ctg12155 novel/mkp3
ET8 TATACAACAAACTTATCTAACGTGCAAT Chr. 2 none
ET9 TATTTAATATATATATTATATTATATTA Chr. 19 novel
Left column, line designation. Sequence column, the genomic sequence the transposon has inserted into. The target TA dinucleotide is highlighted 
in bold. The sequences flanking the left inverted repeat are to the left of the target TA, and sequences flanking the right inverted repeat are to the 
right of the target TA. Lowercase indicates mismatches between an actual sequence read and the current zebrafish genome sequence (Assembly 
ZV3). Both left and right transposon/genomic DNA junctions were sequenced for ET1, ET2, ET3, ET5 and ET7. Only the left junction was read for 
ET8, and only the right junction was read for ET4, ET6 and ET9. Insertion location column, predicted insertion chromosome or contig (Zv3 
assembly of the zebrafish genome). Predicted gene column, the gene into which the transposon has inserted as annotated in the zebrafish genome 
assembly Zv3. Novel indicates no significant homologies. Gene name indicates significant homology to denoted genes. The predicted integration 
into an intron of the PARG locus for line ET2 was experimentally confirmed (see text). For ET7, a comparison of the observed expression pattern 
in this line with that of a known nearby gene (mkp3) indicates this insertion has most likely trapped an enhancer for this gene (Fig. 7, see text). 
Actual sequence reads which were used to determine the genomic location of the transposon insertions were longer than shown in this table and 
are available upon request.Page 10 of 15
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a complete loss of hatching gland-specific GFP expression
(data not shown). While the ET1 line expresses GFP in an
organ that can be readily observed using regular light
microscopy techniques, other lines visualize tissues that
are not nearly as easily morphologically accessible. In par-
ticular, the ET2 line visualizes the position of primary
motoneuron cell bodies and axonal trajectory. Mor-
pholinos against known genes or new members of the
zebrafish secretome [61] can be screened for effects on
neuronal cell body position or axonal pathfinding in the
developing embryos by injection into ET2 line embryos.
The ET7 line may provide a fluorescent readout of FGF8
signaling, thus facilitating the identification of genes
involved in that signaling pathway.
A further utility offered by the transposon system is the
possibility to revert a mutant phenotype or to generate
localized deletions by transposon excision [23]. We suc-
cessfully excised the transposon in the germline of the ET1
line, resulting in the expected transposon footprint. It has
been shown that excision of the Sleeping Beauty transpo-
son from a plasmid results in local deletions with fairly
high frequency which is dependent on the cell type or tis-
sue used [45]. Furthermore, the frequency of imprecise
excision of Sleeping Beauty transposons significantly
increases in cells with a compromised DNA repair
pathway [62,63]. It remains to be determined how fre-
quently the excision of a Sleeping Beauty transposon from
a genomic location in zebrafish germ line is accompanied
by a deletion of flanking genomic DNA, and it should be
possible to compromise the embryo's DNA repair
machinery to induce such deletions at a high frequency.
Our experiments indicate that enhancer detection using
Sleeping Beauty transposons is an easily scalable and
efficient experimental technique in zebrafish. Obtaining
fish with different GFP expression patterns is not the rate
limiting step in this process. Preliminary molecular
analysis of the insertion site is also straightforward using
inverse PCR techniques. Identification of candidate genes
should benefit from the progress in zebrafish genome
sequencing and annotation. The main bottleneck step is
the detailed biological analysis of GFP and the corre-
sponding candidate gene expression profile.
In Drosophila, the generation of transposase-expressing
lines of flies made enhancer detection and P-element
mutagenesis in general a mainstream approach. Even
without a similar gain in efficiency, transposase express-
ing fish lines would make enhancer trapping as well as
related gene- and poly(A)-trap methodologies even more




pT2/S1EF1α-GFP (pDB358) was previously published
[32]. To make γ Cry/pT2/S1EF1α-GFP (pDB375), a
BamHI-HindIII fragment from Cry1-GFP3 [42] containing
part of the X. laevis γ-Cry1 promoter was cloned into the
Ecl136II site of pDB358. To produce pT2/S2EF1α-GFP
(pDB371), a part of the EF1α promoter was deleted from
pDB358 by ligation of the Bst1107I-NcoI and NheI-NcoI
fragments of pDB358. Similarly, the EcoRI-NcoI and NheI-
NcoI fragments of pDB358 were ligated to produce pT2/
S3EF1α-GFP (pDB372).
Inverse PCR, PCR and primer sequences
For inverse PCR experiments, zebrafish genomic DNA was
digested and ligated as described [64]. 1 and 2.5
microliters of the ligation reaction were used for the first
PCR reaction with RP1/LP1 or RP1/GFP-R1 primers in
total volume of 25 µl. 1 µl of the first PCR reaction was
used as a template for the second (nested) PCR reaction
with primer pairs RP2/LP2 or RP2/GFP-R2, respectively.
Expand Hi Fi PCR system (Roche) was used for all PCR
reactions. A MJ Research PTC-100 PCR machine was used
for PCR with the following program : 92°C 4 min., 92°C
10 sec., 60°C 30 sec., 68°C 6 min., 30 cycles. Starting at
cycle 11, 20 sec. per cycle was added to the extension time.
The same PCR reaction with an annealing temperature
55°C was used for amplification with primers flanking
transposon insertion sites, and for amplification of partial
PARG cDNA from a maternal cDNA library. Primer
sequences are: LP1 GTGTCATGCACAAAGTAGATGTCC












Information about other primers is available from the
authors upon request.
In situ hybridization
A partial sequence for the zebrafish poly(ADP-ribose) gly-
cohydrolase cDNA was amplified using primers neuroC1-
F1 and neuroC1-R1 and cloned using a Topo TA cloning
kit (Invitrogen) to make pDB376. To make antisense RNA
probe, pDB376 was digested with SpeI and transcribed
with T7 RNA polymerase (Promega) and DIG labeling kit
(Roche). GFP probe was made by amplifying GFP with 46
base pairs of EF1α promoter from pT2/S1EF1α-GM2 usingPage 11 of 15
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cloning kit resulting in pSS100. pSS100 was linearized
with SpeI and transcribed with T7 RNA polymerase using
DIG labeling kit. To make mkp3 antisense probe, mkp3
cDNA was amplified from maternal cDNA library with
primers Mkp3-F1 and Mkp3-R1 and cloned into Topo TA
cloning kit to produce pDB528. The plasmid was linear-
ized with SpeI and transcribed with T7 polymerase using
DIG labeling kit.
Screening for germline transmission of Sleeping Beauty 
transposons
Embryos injected with SB10 transposase mRNA and trans-
poson DNA mix were raised as described [32,64]. In pilot
screens, adult fish were outcrossed to brass for ease of hus-
bandry. All collected embryos were screened for GFP
expression at 1 day post fertilization (dpf) and 3 dpf. We
set an arbitrary 200 embryo cutoff for screening, meaning
that if less that 200 embryos were obtained from a
founder, an additional cross was set up and to obtain
additional embryos for screening. Analysis of transgenesis
data from pilot screens indicated that 10% of transgenic
lines would have been missed if cutoff was set at 100
embryos, and this less stringent coverage protocol was
used in scale up screen. Also, we decided to limit screening
to 1 dpf since none of the transgenics would have been
missed in the pilot screens without the 3 dpf screening.
Transposon excision in the germline
Homozygous ET1 embryos were injected with SB10 trans-
posase mRNA, raised and screened for loss of hatching
gland specific GFP expression, or for a change in the GFP
expression pattern. Twenty six fish were screened (R0, for
Remobilization), and 2 gave GFP negative embryos, with
an additional 2 giving ubiquitously GFP positive
embryos, suggesting that germline remobilization events
may have occurred in as many as 15% of transposase
injected embryos. Ubiquitous GFP positive embryos (one
in each of the two R0) did not survive. Of the two R0's that
gave GFP negative embryos, one gave mosaic hatching
gland expression in the next generation. PCR with trans-
poson specific and flanking primers did not show any
changes in the locus. The second R0 produced 19 embryos
that were GFP negative from the total of 671 embryos
obtainted. An R1 adult was outcrossed, embryo DNA was
prepared, and PCR with primers HG1-1 and HG1-2 was
conducted. The resulting PCR fragment was cloned using
PCR 4 Topo cloning kit (Invitrogen). Plasmids were
sequenced using M13 Forward primer, and one clone with
a transposon footprint was identified. To confirm that it
was not due to PCR contamination, a second clutch of
embryos was obtained, the procedure was repeated, and
the same footprint was obtained (data not shown).
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